The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - BMS Brazil; MSD Oncology; Roche Molecular Diagnostics
Consulting or Advisory Role - MSD Oncology
A large retrospective analysis of CDK 4/6 inhibitor retreatment in ER+ metastatic breast cancer (MBC).
 
Carlos Henrique Dos Anjos
No Relationships to Disclose
 
Pedram Razavi
Consulting or Advisory Role - Novartis
Research Funding - GRAIL (Inst); Illumina (Inst)
 
Joshua Herbert
No Relationships to Disclose
 
Jodecy Colon
No Relationships to Disclose
 
Kaitlyn Gill
No Relationships to Disclose
 
Shanu Modi
Speakers' Bureau - Genentech
Research Funding - Daiichi Sankyo; Novartis; Roche/Genentech; Seagen; Synta
 
Jacqueline Bromberg
No Relationships to Disclose
 
Chau T. Dang
Research Funding - Genentech/Roche (Inst); Puma Biotechnology (Inst)
Travel, Accommodations, Expenses - Genentech
 
Dazhi Liu
No Relationships to Disclose
 
Larry Norton
Honoraria - Advanced Breast Cancer International Consensus Conference; Bluprint Oncology Concepts; Celgene; Context Therapeutics; MCI Breast Cancer Symposium
Consulting or Advisory Role - Advanced Breast Cancer International Consensus Conference; Bluprint Oncology Concepts; Celgene; Context Therapeutics; MCI Breast Cancer Symposium
Travel, Accommodations, Expenses - Advanced Breast Cancer International Consensus Conference; Celgene; MCI Breast Cancer Symposium
 
Sarat Chandarlapaty
Consulting or Advisory Role - Context Therapeutics; Lilly; Novartis; Sermonix Pharmaceuticals
Research Funding - Daiichi Sankyo (Inst); Genentech (Inst); Lilly (Inst); Novartis (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Novartis; Sun Pharma
 
Mark E. Robson
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; McKesson; Merck; Pfizer
Research Funding - Abbvie (Inst); AstraZeneca (Inst); InVitae (Inst); Medivation (Inst); Myriad Genetics (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Komal L. Jhaveri
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca; Jounce therapeutics; Novartis; Pfizer; Spectrum Pharmaceuticals; Taiho Pharmaceutical
Research Funding - ADC Therapeutics (Inst); Clovis Oncology (Inst); Debiopharm Group (Inst); Genentech (Inst); Novartis (Inst); Novita Pharmaceuticals (Inst); Pfizer (Inst)
Other Relationship - Jounce Therapeutics; Novartis; Pfizer; Taiho Pharmaceutical